Henri Hansson

Title: Henri Hansson: Innovator in Pharmaceutical Compositions

Introduction

Henri Hansson is a notable inventor based in Sweden. He has made significant contributions to the field of pharmaceutical compositions. His work focuses on innovative formulations that enhance therapeutic effects and stability.

Latest Patents

Henri Hansson holds two notable patents. The first is titled "Oil-In-Water Emulsion Of Mometasone And Propylene Glycol." This invention involves novel pharmaceutical compositions of mometasone in the form of an oil-in-water emulsion, notably a cream. The composition boasts excellent stability and therapeutic effect. It contains mometasone in micronised form, propylene glycol, and water, with a weight ratio between propylene glycol and water ranging from 1:1 to about 1:3. The second patent is for an "Improved Snuff Composition." This invention utilizes a nicotine-cellulose combination to prepare a snuff composition that achieves a fast onset of action of nicotine after application. The composition has a high release rate, with about 45% or more of the total nicotine content released within 30 minutes during an in vitro dissolution test.

Career Highlights

Henri Hansson is currently associated with Niconovum AB, a company focused on innovative nicotine products. His work has contributed to advancements in the pharmaceutical industry, particularly in formulations that improve user experience and efficacy.

Collaborations

Henri collaborates with notable colleagues, including Arne Kristensen and Anders Axelsson. Their combined expertise enhances the development of innovative products in the pharmaceutical sector.

Conclusion

Henri Hansson is a dedicated inventor whose work in pharmaceutical compositions demonstrates his commitment to innovation. His contributions have the potential to significantly impact therapeutic practices and improve patient outcomes.